Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Kidney Neoplasms × Vincristine × Clear all

Phase

Status

Unknown 3 Completed 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Burkitt Lymphoma 13 Lymphoma, Large B-Cell, Diffuse 10 Lymphoma, Follicular 7 Lymphoma, B-Cell 7 Rhabdomyosarcoma 6 Neuroblastoma 5 Lymphoma, T-Cell, Peripheral 5 Leukemia, Biphenotypic, Acute 5 Lymphoma 4 Sarcoma, Ewing 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Non-Hodgkin 3 Wilms Tumor 2 Sarcoma 2 Retinoblastoma 2 Recurrence 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Plasmablastic Lymphoma 2 Osteosarcoma 2 Medulloblastoma 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, B-Cell 2 Hodgkin Disease 2 Blastic Plasmacytoid Dendritic Cell Neoplasm 2 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Rhabdomyosarcoma, Embryonal 1 Pleuropulmonary blastoma 1 Pediatric Solid Tumor 1 Optic Nerve Glioma 1

Interventions

cabozantinib 7 pembrolizumab 5 Nivolumab 5 Radiosurgery 3 Ipilimumab 3 Blood Specimen Collection 3 Axitinib 3 lenvatinib 2 Radiotherapy 2 Biopsy 2 zimberelimab 1 tislelizumab 1 polyethylene glycol 3350 1 pazopanib 1 olaparib 1 gallium Ga 68 dotatate 1 brodalumab 1 belzutifan 1 anlotinib 1 adagrasib 1 Watchful Waiting 1 Vincristine 1 Ultrasonography 1 Temozolomide 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sunitinib 1 Standard of Care 1 Radionuclide Imaging 1 Radiofrequency Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05384821 2026-03-18

MetroWilms

Centre Oscar Lambret

Phase 1/2 Recruiting

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡